|Bid||5.10 x 21500|
|Ask||5.14 x 21500|
|Day's range||5.00 - 5.15|
|52-week range||0.47 - 15.69|
|Beta (5Y monthly)||1.98|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
These under-the-radar companies are expected to deliver jaw-dropping revenue growth over the next four years.
BNGO earnings call for the period ending June 30, 2021.
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -20.00% and 16.85%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?